Stockscreener 앱 받기
182.56
0.55%
0.99
시간 외 거래:
182.50
-0.06
-0.03%
전일 마감가:
$181.57
열려 있는:
$182.16
하루 거래량:
1.14M
Relative Volume:
1.10
시가총액:
$20.31B
수익:
$10.52B
순이익/손실:
$999.00M
주가수익비율:
21.83
EPS:
8.3628
순현금흐름:
$1.22B
1주 성능:
+0.03%
1개월 성능:
-2.30%
6개월 성능:
+1.97%
1년 성능:
+16.97%
1일 변동 폭
$181.23
$183.01
1주일 범위
$178.61
$183.50
52주 변동 폭
$148.70
$197.55
퀘스트 다이아그노스틱스 Stock (DGX) Company Profile
명칭
Quest Diagnostics Inc
전화
(973) 520-2700
주소
500 PLAZA DRIVE, SECAUCUS
DGX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
182.56 | 20.20B | 10.52B | 999.00M | 1.22B | 8.3628 |
|
TMO
Thermo Fisher Scientific Inc
|
572.28 | 217.50B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.33 | 164.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
704.20 | 56.49B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
139.68 | 40.44B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.26 | 38.48B | 15.90B | 1.28B | 2.21B | 7.2842 |
퀘스트 다이아그노스틱스 Stock (DGX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-25 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-04-02 | 개시 | Redburn Atlantic | Buy |
| 2025-03-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-01-06 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-12-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | 재개 | Jefferies | Buy |
| 2024-10-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | 재개 | Evercore ISI | In-line |
| 2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-12-12 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-06-29 | 개시 | Piper Sandler | Neutral |
| 2023-05-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-04-03 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-01-23 | 개시 | Evercore ISI | In-line |
| 2022-11-17 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-08-22 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-04-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-02-23 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-02-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-01-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-05-04 | 업그레이드 | UBS | Neutral → Buy |
| 2021-03-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | 업그레이드 | Argus | Hold → Buy |
| 2020-07-29 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-06-09 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-04-28 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-04-27 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | 개시 | Wells Fargo | Underweight |
| 2020-01-07 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-04-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2019-03-18 | 재개 | Credit Suisse | Neutral |
| 2019-01-31 | 다운그레이드 | Argus | Buy → Hold |
| 2019-01-17 | 개시 | UBS | Neutral |
| 2019-01-03 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | 다운그레이드 | Goldman | Buy → Neutral |
모두보기
퀘스트 다이아그노스틱스 주식(DGX)의 최신 뉴스
Looking Into Quest Diagnostics Inc's Recent Short Interest - Sahm
California Public Employees Retirement System Reduces Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
Marshall Wace LLP Reduces Position in Quest Diagnostics Incorporated $DGX - MarketBeat
First Trust Advisors LP Sells 114,868 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Invesco Ltd. Raises Position in Quest Diagnostics Incorporated $DGX - MarketBeat
New York State Common Retirement Fund Sells 7,619 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Can Quest Diagnostics Incorporated (QDI) stock hold up in economic slowdownTrade Exit Report & Safe Entry Zone Identification - Newser
Will Quest Diagnostics Incorporated stock outperform benchmarksJuly 2025 Trends & Real-Time Chart Breakout Alerts - Newser
1,325,624 Shares in Quest Diagnostics Incorporated $DGX Purchased by Norges Bank - MarketBeat
Korea Investment CORP Purchases 12,300 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Published on: 2025-12-03 05:06:27 - Newser
Blueshift Asset Management LLC Has $636,000 Stock Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Is Quest Diagnostics Incorporated (QDI) stock ideal for retirement investorsPortfolio Performance Report & Daily Volume Surge Signals - Newser
Is Quest Diagnostics Incorporated stock nearing a technical breakoutExit Point & Expert Approved Momentum Ideas - Newser
Mackenzie Financial Corp Has $28.11 Million Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Schroder Investment Management Group Buys 122,646 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Is Quest Diagnostics Incorporated stock cheap vs fundamentalsJuly 2025 Snapshot & AI Forecasted Stock Moves - Newser
Why analysts maintain buy rating on Quest Diagnostics Incorporated stockBreakout Watch & Low Drawdown Momentum Ideas - Newser
Russell Investments Group Ltd. Acquires 25,768 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Published on: 2025-12-02 04:36:26 - Newser
How cyclical is Quest Diagnostics Incorporated stock compared to rivals2025 Analyst Calls & Real-Time Chart Breakout Alerts - Newser
Distillate Capital Partners LLC Sells 4,577 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Hsbc Holdings PLC Reduces Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock - sharewise.com
Quest Diagnostics Inc. stock underperforms Monday when compared to competitors - MarketWatch
Quest Diagnostics, Octave Collaborate to Expand Multiple Sclerosis Disease Activity Test Access - marketscreener.com
Octave Bio lands massive deal with Quest Diagnostics that will expand reach of its multiple sclerosis tests - The Business Journals
Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave - Business Wire
First National Advisers LLC Purchases Shares of 8,980 Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Insider Sold Shares Worth $10,589,760, According to a Recent SEC Filing - marketscreener.com
Skandinaviska Enskilda Banken AB publ Raises Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
J. Davis Sells 55,093 Shares of Quest Diagnostics (NYSE:DGX) Stock - MarketBeat
Quest Diagnostics Incorporated $DGX Shares Sold by Grantham Mayo Van Otterloo & Co. LLC - MarketBeat
Northwest & Ethical Investments L.P. Invests $1.10 Million in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Incorporated $DGX Stock Holdings Lifted by Franklin Resources Inc. - MarketBeat
Prudential Financial Inc. Grows Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Does Quest Diagnostics Offer Value After 8% Surge and New Partnerships in 2025? - Yahoo Finance
Insider Sell: Vicky Gregg Sells Shares of Quest Diagnostics Inc (DGX) - GuruFocus
Chmn Davis Sells 55,093 ($10.6M) Of Quest Diagnostics Inc [DGX] - TradingView
Dir Gregg Sells 1,250 ($239.7K) Of Quest Diagnostics Inc [DGX] - TradingView
Quest Diagnostics (DGX) CEO James E. Davis exercises options and sells common stock - Stock Titan
[Form 4] QUEST DIAGNOSTICS INC Insider Trading Activity - Stock Titan
Advisors Asset Management Inc. Reduces Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Incorporated $DGX Shares Acquired by Charles Schwab Investment Management Inc. - MarketBeat
Can Quest Diagnostics Incorporated stock deliver sustainable ROEQuarterly Profit Report & AI Driven Stock Price Forecasts - BỘ NỘI VỤ
HOLX vs. DGX: Which Healthcare Diagnostics Stock Is the Better Bet? - Finviz
Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term - sharewise.com
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Boston Partners Has $545.32 Million Position in Quest Diagnostics Incorporated $DGX - MarketBeat
[144] QUEST DIAGNOSTICS INC SEC Filing - Stock Titan
Dir Gregg Files To Sell 1,250 Of Quest Diagnostics Inc [DGX] - TradingView
퀘스트 다이아그노스틱스 (DGX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.15%
0.39%
자본화:
|
볼륨(24시간):